Status:
UNKNOWN
A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases
Lead Sponsor:
Tang-Du Hospital
Collaborating Sponsors:
LinkDoc Technology (Beijing) Co. Ltd.
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
Brief Summary
An observational study to explore prognoses and clinical treatments of the patients with non-small cell lung cancer complicated with oligometastases
Detailed Description
A multi-centre real-world non-interventional observational study to explore prognoses and clinical treatments of the patients with non-small lung cancer complicated with oligometastases
Eligibility Criteria
Inclusion
- Pathologically diagnosed patients with non-small cell lung cancer;
- Tumor metastases in one organ (no more than 3 metastases);
Exclusion
- Patients with intrapulmonary metastases or multiple primary tumors;
- Patients with pleural dissemination or invasion of extrapulmonary organs;
- Patients with supraclavicular lymph node metastasis;
- Patients with systematic diseases that would influence patient survivals;
- Patients with no records for visits;
Key Trial Info
Start Date :
December 31 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2018
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03427541
Start Date
December 31 2017
End Date
April 30 2018
Last Update
February 9 2018
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029
2
China PLA General Hospital
Beijing, Beijing Municipality, China, 100853
3
Henan cancer hospital
Zhengzhou, Henan, China, 450008
4
Tongji Hospital Affiliated to Huazhong Technology Hospital
Wuhan, Hubei, China, 430030